More than 110 drugs, capable of penetrating this elusive barrier are currently being evaluated for the treatment of CNS disorders; there are nearly 35 technology platforms for the development of BBB penetrant drugs, claims Roots Analysis

Written by

To order this 400+ page report, which features 145+ figures and 205+ tables, please visit

2 weeks ago
0 0